BioLattice Ophthalmics, Inc, · CIK 2125596
BioLattice Ophthalmics, Inc,
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
1
Amendments
1
Activity
Mar 30, 2026
through Oct 28, 2026
through Oct 28, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Mar 30, 2026 · D | Oct 28, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $2,500,000 | $3,310,000 | $810,000 |
| Reported amount sold | $575,000 | $1,825,000 | $1,250,000 |
| Reported investor count | — | 7 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002125596-26-000001 · Later SEC source: 0002125596-26-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $3,310,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $1,825,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0002125596-26-000003D/A · Oct 28, 2026 · BiotechnologyOffering: $3,310,000Sold: $1,825,000
Compared with 0002125596-26-000001:
- Reported offering amount: $2,500,000 → $3,310,000
- Reported amount sold: $575,000 → $1,825,000
- Reported investor count: Unavailable → 7
-
0002125596-26-000001D · Mar 30, 2026 · BiotechnologyOffering: $2,500,000Sold: $575,000